130 related articles for article (PubMed ID: 6173122)
1. Methotrexate cytotoxicity: studies on its reversal by folates and nucleosides.
Leyva A; Nederbragt H; Lankelma J; Pinedo HM
Cancer Treat Rep; 1981; 65 Suppl 1():45-50. PubMed ID: 6173122
[TBL] [Abstract][Full Text] [Related]
2. Analysis of "early" thymidine/inosine protection as an adjunct to methotrexate therapy.
Eleff M; Franks PE; Wampler GL; Collins JM; Goldman ID
Cancer Treat Rep; 1985; 69(7-8):867-74. PubMed ID: 2410122
[TBL] [Abstract][Full Text] [Related]
3. Critical modulation by thymidine and hypoxanthine of sequential methotrexate-5-fluorouracil synergism in murine L1210 cells.
Piper AA; Nott SE; Mackinnon WB; Tattersall MH
Cancer Res; 1983 Nov; 43(11):5101-5. PubMed ID: 6616448
[TBL] [Abstract][Full Text] [Related]
4. [Use of purine rescue pathways by L1210 cells exposed to methotrexate in vitro].
Buesa JM
Rev Esp Oncol; 1982; 29(4):641-7. PubMed ID: 6085740
[TBL] [Abstract][Full Text] [Related]
5. Improved therapeutic index with high-dose methotrexate: comparison of thymidine-purine rescue with citrovorum factor rescue in mice.
Samuels LL; Straw JA
Cancer Res; 1984 Jun; 44(6):2278-84. PubMed ID: 6609764
[TBL] [Abstract][Full Text] [Related]
6. The reversal of methotrexate cytotoxicity to mouse bone marrow cells by leucovorin and nucleosides.
Pinedo HM; Zaharko DS; Bull JM; Chabner BA
Cancer Res; 1976 Dec; 36(12):4418-24. PubMed ID: 1087180
[TBL] [Abstract][Full Text] [Related]
7. Reversal of methotrexate inhibition of colony growth of L1210 leukemia cells in semisolid medium.
Nederbragt H; Uitendaal MP; van der Grint L; Leyva A; Pinedo HM
Cancer Res; 1981 Mar; 41(3):1193-8. PubMed ID: 6970074
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate cytotoxicity in cultured human leukemic cells studied by flow cytometry.
Taylor IW; Tattersall MH
Cancer Res; 1981 Apr; 41(4):1549-58. PubMed ID: 6163527
[TBL] [Abstract][Full Text] [Related]
9. [Potentiated antitumor effect of methotrexate by dipyridamole].
Cao SS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1989 Feb; 11(1):7-12. PubMed ID: 2527632
[TBL] [Abstract][Full Text] [Related]
10. Purine modulation of methotrexate cytotoxicity in mammalian cell lines.
Taylor IW; Slowiaczek P; Francis PR; Tattersall MH
Cancer Res; 1982 Dec; 42(12):5159-64. PubMed ID: 6958362
[TBL] [Abstract][Full Text] [Related]
11. Effect of methotrexate on 5-phosphoribosyl 1-pyrophosphate levels in L1210 leukemia cells in vitro.
Buesa-Perez JM; Leyva A; Pinedo HM
Cancer Res; 1980 Jan; 40(1):139-44. PubMed ID: 6243086
[No Abstract] [Full Text] [Related]
12. Effects of extracellular purines on cytotoxicity of methotrexate.
Chong L; Ma G; Bartier WA; Tattersall MH
Cancer Chemother Pharmacol; 2010 May; 66(1):121-7. PubMed ID: 19784836
[TBL] [Abstract][Full Text] [Related]
13. The mechanism of transport of the multitargeted antifolate (MTA) and its cross-resistance pattern in cells with markedly impaired transport of methotrexate.
Zhao R; Babani S; Gao F; Liu L; Goldman ID
Clin Cancer Res; 2000 Sep; 6(9):3687-95. PubMed ID: 10999762
[TBL] [Abstract][Full Text] [Related]
14. [Biochemical modulation in cancer chemotherapy].
Kawasaki H; Nobori T; Kamiya H; Sakurai M
Gan To Kagaku Ryoho; 1985 Apr; 12(4):815-29. PubMed ID: 3985645
[TBL] [Abstract][Full Text] [Related]
15. Osteosarcoma cells, resistant to methotrexate due to nucleoside and nucleobase salvage, are sensitive to nucleoside analogs.
Cole PD; Smith AK; Kamen BA
Cancer Chemother Pharmacol; 2002 Aug; 50(2):111-6. PubMed ID: 12172974
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of reduced folate carrier gene (RFC1) expression after exposure to methotrexate in ZR-75-1 breast cancer cells.
Ma D; Huang H; Moscow JA
Biochem Biophys Res Commun; 2000 Dec; 279(3):891-7. PubMed ID: 11162445
[TBL] [Abstract][Full Text] [Related]
17. Activity of free and carrier-bound methotrexate against transport-deficient and high dihydrofolate dehydrogenase-containing methotrexate-resistant L1210 cells.
Chu BC; Fan CC; Howell SB
J Natl Cancer Inst; 1981 Jan; 66(1):121-4. PubMed ID: 6935452
[TBL] [Abstract][Full Text] [Related]
18. Establishment of methotrexate-resistant human acute lymphoblastic leukemia cells in culture and effects of folate antagonists.
Ohnoshi T; Ohnuma T; Takahashi I; Scanlon K; Kamen BA; Holland JF
Cancer Res; 1982 May; 42(5):1655-60. PubMed ID: 6978176
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of DNA synthesis and enhancement of the uptake and action of methotrexate by low-power-density microwave radiation in L1210 leukemia cells.
Chang BK; Huang AT; Joines WT
Cancer Res; 1980 Apr; 40(4):1002-5. PubMed ID: 7357530
[TBL] [Abstract][Full Text] [Related]
20. Methotrexate with thymidine, inosine, and allopurinol rescue: a phase I clinical study.
Dady PJ; Taylor GA; Muindi JF; Calvert AH; Smith IE; Smyth JF; Harrap KR
Cancer Treat Rep; 1981; 65 Suppl 1():37-43. PubMed ID: 7326664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
